In silico identification of potential drug compound against Peroxisome proliferator-activated receptor-gamma by virtual screening and toxicity studies for the treatment of Diabetic Nephropathy

Molecular dynamics simulation integrating the inhibition kinetics of hydroxysafflor yellow A on α-glucosidase

(2017) Yingying Xu et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Molecular modeling, dynamics studies and density functional theory approaches to identify potential inhibitors of SIRT4 protein from Homo sapiens : a novel target for the treatment of type 2 diabetes

(2016) Sanjay K. Choubey et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Diabetes mellitus caused by mutations in human insulin: analysis of impaired receptor binding of insulinsWakayama,Los AngelesandChicagousing pharmacoinformatics

(2016) Md Ataul Islam et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Molecular modeling study for the design of novel acetyl-CoA carboxylase inhibitors using 3D QSAR, molecular docking and dynamic simulations

(2016) Vivek K. Vyas et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

A computational study on role of 6-(hydroxymethyl)-3-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxyoxane-2,4,5-triol in the regulation of blood glucose level

(2016) Karthikeyan Muthusamy et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis

(2015) Akhil Kumar et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists

(2015) Vinicius G. Maltarollo et al.   PLoS One

In SilicoIdentification of Potent PPAR-γAgonists from Traditional Chinese Medicine: A Bioactivity Prediction, Virtual Screening, and Molecular Dynamics Study

(2014) Kuan-Chung Chen et al.   Evidence-based Complementary and Alternative Medicine

New Insights into the PPARγAgonists for the Treatment of Diabetic Nephropathy

(2014) Zhanjun Jia et al.   PPAR Research

PPARγ signaling and metabolism: the good, the bad and the future

(2013) Maryam Ahmadian et al.   NATURE MEDICINE

Thiazolidinedione safety

(2012) Jacqueline Kung et al.   Expert Opinion On Drug Safety

Computational screening for new inhibitors ofM. tuberculosismycolyltransferases antigen 85 group of proteins as potential drug targets

(2012) Shachi Gahoi et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) γ Activators and Pan-PPAR Partial Agonists

(2012) Marcelo Vizoná Liberato et al.   PLoS One

iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis

(2011) Kai-Cheng Hsu et al.   BMC BIOINFORMATICS

Validation of the GROMOS 54A7 Force Field with Respect to β-Peptide Folding

(2011) Wei Huang et al.   Journal of Chemical Theory and Computation

Effect of Thiazolidinediones on Albuminuria and Proteinuria in Diabetes: A Meta-analysis

(2010) Pantelis A. Sarafidis et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Structural requirement for PPARγ binding revealed by a meta analysis of holo-crystal structures

(2010) Alessandro S. Nascimento   BIOCHIMIE

AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

(2009) Oleg Trott et al.   JOURNAL OF COMPUTATIONAL CHEMISTRY

A QSAR Study on Indole-Based PPAR-γ Agonists in Respect to Receptor Binding and Gene Transactivation Data

(2009) Costas Giaginis et al.   Quantitative structure-activity relationships & combinatorial science